Izotropic Corporation (FRA:1R3)
0.1870
-0.0130 (-6.50%)
At close: Dec 1, 2025
Izotropic Company Description
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers.
The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast.
Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation
| Country | Canada |
| Founded | 2016 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| CEO | Robert Thast |
Contact Details
Address: 800-15355 24th Avenue Surrey, V4A 2H9 Canada | |
| Phone | (833) 496-2677 |
| Website | izocorp.com |
Stock Details
| Ticker Symbol | 1R3 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Robert Thast | Chief Executive Officer |
| Ralph Proceviat | Chief Financial Officer |
| Younes Achkire | Chief Operating Officer |